4qpf: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "4qpf" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 3: | Line 3: | ||
The entry 4qpf is ON HOLD | The entry 4qpf is ON HOLD | ||
Authors: Ebetino, F.H., Lundy, M., Kwaasi, A.A., Dunford, J.E., Duan, Z., Triffitt, J., Mazur, A., Jeans, G., Barnett, B.L., Russell, | Authors: Ebetino, F.H., Lundy, M., Kwaasi, A.A., Dunford, J.E., Duan, Z., Triffitt, J., Mazur, A., Jeans, G., Barnett, B.L., Russell, R.G.G. | ||
Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption | Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption | ||
Revision as of 09:47, 16 July 2014
Unreleased structure
The entry 4qpf is ON HOLD
Authors: Ebetino, F.H., Lundy, M., Kwaasi, A.A., Dunford, J.E., Duan, Z., Triffitt, J., Mazur, A., Jeans, G., Barnett, B.L., Russell, R.G.G.
Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption
